Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3798243 | 0.93 | MEN1 (0.32) | ALDH1A1MEN1KMT2A | |
| SCHEMBL3796589 | 0.92 | GFER (0.34) | KDM4EALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3792570 | 0.90 | GRIN1 (0.33) | KDM4EALDH1A1 | |
| SCHEMBL3803161 | 0.89 | — | — | |
| SCHEMBL3792294 | 0.87 | MEN1 (0.32) | MEN1KMT2A | |
| SCHEMBL3804527 | 0.87 | KDM4E (0.32) | KDM4EALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3804518 | 0.87 | TACR1 (0.34) | ALDH1A1MEN1KMT2A | |
| SCHEMBL3799072 | 0.86 | GFER (0.33) | ALDH1A1 | |
| SCHEMBL3798367 | 0.83 | ALDH1A1 (0.34) | KDM4EALDH1A1MEN1KMT2A | |
| SCHEMBL3797978 | 0.83 | OPRK1 (0.33) | ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | claimed |
| CN-101702907-A | Piperazine compounds with a herbicidal action | BASF SE | 2010-05-05 | — | — | CN | claimed |
| CN-101677540-A | Herbicidally effective composition | EIKE HUPE | 2010-03-24 | — | — | CN | claimed |
| CN-101679316-A | Piperazine compounds with a herbicidal action | BASF SE | 2010-03-24 | — | — | CN | claimed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | claimed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | claimed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | claimed |
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | BASF SE (DE) | 2010-07-08 | — | — | US | disclosed |
| CN-101702907-A | Piperazine compounds with a herbicidal action | BASF SE | 2010-05-05 | — | — | CN | disclosed |
| CN-101677540-A | Herbicidally effective composition | EIKE HUPE | 2010-03-24 | — | — | CN | disclosed |
| CN-101679316-A | Piperazine compounds with a herbicidal action | BASF SE | 2010-03-24 | — | — | CN | disclosed |
| EP-2054394-B1 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2009-11-18 | — | — | EP | disclosed |
| EP-2054394-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | Basf Se (DE) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008152072-A2 | PIPERAZINE COMPOUNDS WITH A HERBICIDAL ACTION | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100173777-A1 | Piperazine Compounds Having Herbicidal Action | CBR3, CBR1, CNPY2 | KDM4E 4069/4885ALDH1A1 1174/4885HSD17B10 390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.